The purpose of the company is to provide services in the fields of research, development, manufacturing, registration, promotion, marketing, and trade of products in the areas of information technology, biotechnology, pharmacy, medical technology, diagnosis, and therapy. The company also aims to acquire, archive, use, and commercially exploit data from these fields. The company may acquire, develop, encumber, sell, and manage licenses, patents, and other intangible assets, as well as real estate, and conduct all business that is directly or indirectly related to its purpose. The company may engage in investment and lending transactions of any kind, provide guarantees, and grant direct or indirect financing to affiliated companies or third parties, including its direct or indirect shareholders and their direct or indirect subsidiaries, and provide security for the liabilities of such other companies, including by way of pledges or fiduciary transfers of the company's assets or guarantees of any kind, whether for consideration or not. Furthermore, it may operate a liquidity adjustment / concentration of net liquidity (cash pooling) with the aforementioned companies or join such a system, including periodic account settlement (zero balancing), also under preferential conditions without interest, excluding the company's profit motive, and assuming cluster risks. The company may establish branches and subsidiaries in Switzerland and abroad.